Zobrazeno 1 - 10
of 13
pro vyhledávání: '"ChaoZhong Song"'
Autor:
Jie Liu, John T. Halloran, Jeffrey A. Bilmes, Riza M. Daza, Choli Lee, Elisabeth M. Mahen, Donna Prunkard, Chaozhong Song, Sibel Blau, Michael O. Dorschner, Vijayakrishna K. Gadi, Jay Shendure, C. Anthony Blau, William S. Noble
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Abstract A comprehensive characterization of tumor genetic heterogeneity is critical for understanding how cancers evolve and escape treatment. Although many algorithms have been developed for capturing tumor heterogeneity, they are designed for anal
Externí odkaz:
https://doaj.org/article/c58b18b457184aafaf83bba3e97a5fdf
Autor:
Habil Zare, Junfeng Wang, Alex Hu, Kris Weber, Josh Smith, Debbie Nickerson, ChaoZhong Song, Daniela Witten, C Anthony Blau, William Stafford Noble
Publikováno v:
PLoS Computational Biology, Vol 10, Iss 7, p e1003703 (2014)
Cancers arise from successive rounds of mutation and selection, generating clonal populations that vary in size, mutational content and drug responsiveness. Ascertaining the clonal composition of a tumor is therefore important both for prognosis and
Externí odkaz:
https://doaj.org/article/966e1c18193d463e897220f2d7f45c26
Autor:
Michelle L. Christian, Michael J. Dapp, Samuel C. Scharffenberger, Hank Jones, Chaozhong Song, Lisa M. Frenkel, Anthony Krumm, James I. Mullins, David J. Rawlings
Publikováno v:
The Journal of Immunology. 208:1700-1710
One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (ISs) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same trans
Autor:
Kimberly A. Burton, Elisabeth Mahen, Eric Quentin Konnick, Sibel Blau, Michael O. Dorschner, Arturo B. Ramirez, Stephen C. Schmechel, Chaozhong Song, Rahul Parulkar, Stephanie Parker, Francis Mark Senecal, Colin C. Pritchard, Brigham H. Mecham, Christopher Szeto, Patricia Spilman, Jingchun Zhu, Vijayakrishna K. Gadi, Roy Ronen, Jackie Stilwell, Eric Kaldjian, Janusz Dutkowski, Stephen Charles Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, C. Anthony Blau
Publikováno v:
JCO Precision Oncology.
PURPOSE Patients with metastatic triple-negative breast cancer (mTNBC) have poor outcomes. The Intensive Trial of Omics in Cancer (ITOMIC) sought to determine the feasibility and potential efficacy of informing treatment decisions through multiple bi
Publikováno v:
2021 China Automation Congress (CAC).
Autor:
Michelle L, Christian, Michael J, Dapp, Samuel C, Scharffenberger, Hank, Jones, Chaozhong, Song, Lisa M, Frenkel, Anthony, Krumm, James I, Mullins, David J, Rawlings
Publikováno v:
J Immunol
One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (IS) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same transc
Autor:
Julie Mathieu, Jason W. Miklas, Christopher Cavanaugh, Abdiasis M. Hussein, Walter L. Ruzzo, Oliver Fiehn, Megan R. Showalter, Hannele Ruohola-Baker, Chaozhong Song, C. Anthony Blau, Yuliang Wang, Lilyana Margaretha, Elisabeth Mahen, Daniel C. Jones, Carol B. Ware
Publikováno v:
Dev Cell
Regulation of embryonic diapause, dormancy that interrupts the tight connection between developmental stage and time, is still poorly understood. Here, we characterize the transcriptional and metabolite profiles of mouse diapause embryos and identify
Autor:
Sibel Blau, William Stafford Noble, Choli Lee, Donna Prunkard, Michael O. Dorschner, C. Anthony Blau, Jie Liu, John T. Halloran, Chaozhong Song, Jeff A. Bilmes, Vijayakrishna K. Gadi, Jay Shendure, Riza M. Daza, Elisabeth Mahen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
A comprehensive characterization of tumor genetic heterogeneity is critical for understanding how cancers evolve and escape treatment. Although many algorithms have been developed for capturing tumor heterogeneity, they are designed for analyzing eit
Autor:
C. Anthony Blau, Carol Collins, Wayne Monsky, Nathan D. Price, William Stafford Noble, Michael O. Dorschner, Linda Dhaene, Brigham H. Mecham, Arturo Ramirez, Aime Radenbaugh, Jackie L. Stilwell, Chaozhong Song, Nicole M. Kuderer, Julie R. Gralow, Elisabeth Mahen, Colin C. Pritchard, Carla Grandori, David Haussler, Jeannine S. McCune, Mary Goldman, Frank Senecal, Kimberly A. Burton, Vijayakrishna K. Gadi, Jennifer M. Specht, Eric Kladjian, Sibel Blau, Jingchun Zhu
Publikováno v:
Cancer Research. 75:P4-08
We hypothesize that new insights into how cancers progress and respond to treatment will come from clinical trials that i) extensively characterize the molecular features of a patient’s cancer; ii) use results to predict drug susceptibilities; iii)
Autor:
Elisabeth Mahen, William Stafford Noble, Jingchun Zhu, Michael O. Dorschner, Chaozhong Song, Gadi, Stephen C. Benz, Sibel Blau, Carl Anthony Blau, Stephen C. J. Parker, Jie Liu, Komashko, Stephen C. Schmechel, Zhijun Duan, Shelly Heimfeld, Goldsmith J, Kimberly A. Burton, Johnsen J, Naozumi Hiranuma, Francis M. Senecal, David Haussler, Walter L. Ruzzo, Colin C. Pritchard, Allison S, Sofie R. Salama, Wayne Monsky, LaMadrid-Hermannsfeldt M, Patrick Soon-Shiong, Mary Goldman, Amie Radenbaugh
About 16% of breast cancers fall into a clinically aggressive category designated triple negative (TNBC) due to a lack of ERBB2, estrogen receptor and progesterone receptor expression1-3. The mutational spectrum of TNBC has been characterized as part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf4cdd2aebfde8917b2d88759e2ed2e0
https://doi.org/10.1101/085316
https://doi.org/10.1101/085316